SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001009448-09-000060
Filing Date
2009-08-11
Accepted
2009-08-11 16:18:28
Documents
1
Period of Report
2009-07-30

Document Format Files

Seq Description Document Type Size
1 form4biotex_ex.html 4  
1 form4biotex_ex.xml 4 4222
  Complete submission text file 0001009448-09-000060.txt   6230
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-452-0001
DOR BIOPHARMA INC (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 220 WEST 42ND STREET 6TH FLOOR NEW YORK NY 10036
Business Address 212-763-5550
Biotex Pharma Investments, LLC (Reporting) CIK: 0001467543 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 091003972